PLCG2 and B-cell chronic lymphocytic leukemia: Several nonsynonymous mutations in PLCγ2 have been described in Ibrutinib-resistant CLL, with the majority of them occurring in the SH2 domain including the P664S, R665W and S707* [51,55,56,59,60,61,62,63].